Patients with BolA3 mutations were susceptible to various diseases and disorders, such as cardiomyopathy, abnormally high glycine levels in the serum, seizures, spasticity, and hypotonia (Cameron et al., 2011; Haack et al., 2013; Nikam et al., 2018; Talib and Outten, 2021). The gene discussed is BOLA3; the disease is cardiomyopathy.